However, MEG3 expression in PBMCs in the context of GDM is less likely to correlate with expression in the placenta compared to other candidate lncRNAs, since the placenta is among tissue types that exhibit the highest MEG3 levels, while PBMCs show markedly lower expression. Here, MEG3 is linked to gestational diabetes.